Related Experiment Videos
Expression of transforming growth factor-beta isoforms and their receptors in chronic tendinosis
S A Fenwick1, V Curry, R L Harrall
1Rheumatology Research Unit, Addenbrookes Hospital, Cambridge, UK.
Abstract:
Chronic tendon lesions are degenerative conditions and may represent a failure to repair or remodel the extracellular matrix after repeated micro-injury. Since TGF-beta is strongly associated with tissue repair, we investigated the expression of TGF-beta isoforms (beta1, beta2 and beta3) and their 2 signalling receptors (TGF-betaRI and TGF-betaRII) in normal and pathological Achilles tendons. In all tissues, all 3 TGF-beta isoforms and the 2 receptors were present at sites of blood vessels. Cells in the matrix showed no staining for TGF-beta1 or beta3, while TGF-beta2 was associated with cells throughout the normal cadaver tendon. Tissue from tendons with pathological lesions showed an increase in cell numbers and percentage TGF-beta2 expression. TGF-betaRII showed a wide distribution in cells throughout the tissue sections. As with TGF-beta2, there was an increase in the number of cells expressing TGF-betaRII in pathological tissue. TGF-betaRI was restricted to blood vessels and was absent from the fibrillar matrix. We conclude that despite the presence and upregulation of TGF-beta2, TGF-beta signalling is not propagated due to the lack of TGF-betaRI. This might explain why chronic tendon lesions fail to resolve and suggests that the addition of exogenous TGF-beta will have little effect on chronic tendinopathy.
Insights
Chronic tendon lesions fail to heal because TGF-beta signaling is blocked. Despite increased TGF-beta2, the lack of TGF-betaRI in cells prevents repair, suggesting limited benefit from exogenous TGF-beta for tendinopathy.
Area of Science:
- Biomedical Science
- Extracellular Matrix Biology
- Tissue Repair Mechanisms
Background:
- Chronic tendon lesions are degenerative, linked to extracellular matrix remodeling failures after micro-injury.
- Transforming growth factor-beta (TGF-beta) is crucial for tissue repair processes.
Purpose of the Study:
- To investigate the expression of TGF-beta isoforms (beta1, beta2, beta3) and their signaling receptors (TGF-betaRI, TGF-betaRII) in normal and pathological Achilles tendons.
- To understand the molecular mechanisms behind the failure of chronic tendon lesions to resolve.
Main Methods:
- Immunohistochemical analysis of TGF-beta isoforms and their receptors in normal and pathological Achilles tendon tissue.
- Quantitative assessment of cell numbers and protein expression in different tendon regions.
Main Results:
- All TGF-beta isoforms and receptors were found at blood vessel sites.
- TGF-beta2 and TGF-betaRII expression increased in cells within pathological tendons.
- TGF-betaRI was exclusively located in blood vessels, absent from the fibrillar matrix.
Conclusions:
- Despite increased TGF-beta2 and TGF-betaRII in pathological tendons, TGF-beta signaling is not propagated due to the absence of TGF-betaRI in the cellular matrix.
- This lack of signaling may explain the failure of chronic tendon lesions to resolve.
- Exogenous TGF-beta administration is unlikely to be effective for treating chronic tendinopathy.